Literature DB >> 16730122

Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism.

K-T von Trotha1, R Heun, S Schmitz, D Lütjohann, W Maier, H Kölsch.   

Abstract

Linkage analyses have identified a possible hot spot for a late-onset Alzheimer's disease (LOAD) risk gene on chromosome 10q21-22 and 10q25. It was also shown that cholesterol metabolism is involved in the pathogenic mechanisms of AD. The gene of lysosomal acid lipase (LIPA) is located next to the putative hot spot on chromosome 10. Its protein is involved in cholesterol metabolism and responsible for catalysing the hydrolysis of cholesteryl esters and triglycerides inside the lysosome. Previous publications reported controversial results on the role of LIPA polymorphisms on the risk of LOAD. We investigated two LIPA polymorphisms (rs1051338 and rs2297472) for their putative effect on the risk of LOAD in a homogenous sample of German origin. Genotypes of the investigated polymorphisms in AD patients and controls were compared. Also the effect of the LIPA gene polymorphisms on plasma cholesterol levels and 24S-hydroxycholesterol/cholesterol ratios on AD patients were investigated. None of the observed polymorphisms showed a significant influence on the risk of AD. We found that LIPA exon 2 polymorphism (rs1051338) influenced plasma 24S-hydroxycholesterol/cholesterol ratios in AD patients where carriers of the C/C allele presented with higher ratios than heterozygote carriers of the LIPA allele. Even though the biological function and gene location of LIPA on chromosome 10 suggest that LIPA might be a candidate for an AD risk gene, our results revealed that polymorphisms in LIPA did not influence the risk of AD in our study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730122     DOI: 10.1016/j.neulet.2006.04.009

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Polymorphisms in ABLIM1 are associated with personality traits and alcohol dependence.

Authors:  Ke-Sheng Wang; Xuefeng Liu; Nagesh Aragam; Jerald E Mullersman; Xueqiu Jian; Yue Pan; Yali Liu
Journal:  J Mol Neurosci       Date:  2011-05-06       Impact factor: 3.444

2.  LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.

Authors:  Kristin L Bowden; Joshua A Dubland; Teddy Chan; You-Hai Xu; Gregory A Grabowski; Hong Du; Gordon A Francis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

3.  RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism.

Authors:  Heike Kölsch; Dieter Lütjohann; Frank Jessen; Julius Popp; Frank Hentschel; Peter Kelemen; Silvia Friedrichs; T A Wolfgang Maier; Reinhard Heun
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

4.  Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease.

Authors:  Andrew T McKenzie; Sarah Moyon; Minghui Wang; Igor Katsyv; Won-Min Song; Xianxiao Zhou; Eric B Dammer; Duc M Duong; Joshua Aaker; Yongzhong Zhao; Noam Beckmann; Pei Wang; Jun Zhu; James J Lah; Nicholas T Seyfried; Allan I Levey; Pavel Katsel; Vahram Haroutunian; Eric E Schadt; Brian Popko; Patrizia Casaccia; Bin Zhang
Journal:  Mol Neurodegener       Date:  2017-11-06       Impact factor: 14.195

5.  Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.

Authors:  Andrea Pasta; Paolo Borro; Anna Laura Cremonini; Elena Formisano; Giulia Tozzi; Stefano Cecchi; Raffaele Fresa; Sara Labanca; Afscin Djahandideh; Samir Giuseppe Sukkar; Antonino Picciotto; Livia Pisciotta
Journal:  Pharmacol Res Perspect       Date:  2021-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.